Perfusion MRI of U87 Brain Tumors in a Mouse Model

Magnetic Resonance in Medicine

Volumn 51, Issue 5, 2004, Pages 893-899

  Sun, Yanping ^a   Schmidt, Nils O ^a   Schmidt, Karl ^a   Doshi, Sameer ^a   Rubin, Joshua B ^b   Mulkern, Robert V ^c   Carroll, Rona ^a   Ziu, Mateo ^a   Erkmen, Kadir ^a   Poussaint, Tina Y ^c   Black, Peter ^a   Albert, Mitchell ^a   Burstein, Deborah ^d   Kieran, Mark W ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Antiangiogenesis; Arterial spin labeling; Brain tumor in mouse model; Perfusion MRI

Indexed keywords

BLOOD; BRAIN;

ANTI-ANGIOGENIC THERAPY; ANTIANGIOGENESIS; ARTERIAL SPIN LABELING; CONTINUOUS ARTERIAL SPIN LABELING; IMMUNOHISTOCHEMISTRY; MICROVESSEL DENSITY; MOUSE MODELS; PERFUSION MRI;

TUMORS;

ANGIOGENESIS INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; BRAIN TISSUE; BRAIN TUMOR; BRAIN WATER; CONTINUOUS ARTERIAL SPIN LABELING; CONTROLLED STUDY; DRUG EFFICACY; GLIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION NUCLEAR MAGNETIC RESONANCE IMAGING; SPIN LABELING; TUMOR VASCULARIZATION;

EID: 1642409487     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20029     Document Type: Article

References (38)

1. Holland EC. Glioblastoma multiform: the terminator. Proc Natl Acad Sci USA 2000;97:6242-6244.
2. Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999;46:183-188.
3. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-372.
4. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic complication. Cancer 1985;56:1106-1111.
5. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62:2152-2165.
6. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255-268.
7. Tatsuhiro J, Machluf M, Atala A, Zhu J, Seyfried N, Dunn IF, Abe T, Carroll RS, Black P. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nature Biotechnology 2001;19:35-39.
8. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H, Hallahan DE. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 2001;61:2413-2419.
9. Peroulis I, Jonas N, Saleh M. Antiangiogenic activity of endostatin inhibits C6 glioma growth. Int J Cancer 2002;20:839-845.
10. Ma HI, Lin SZ, Chiang YH, Li J, Chen SL, Tsao YP, Xiao X. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Ther 2002;9:2-11.
11. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius HJ, Kiss R. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 2002;61:585-596.
12. Zhang Y, Zhu C, Pardridge WM. Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 2002;6:67-72.
13. Samoto K, Ehtesham M, Perng GC, Hashizume K, Wechsler SL, Nesburn AB, Black KL, Yu JS. A herpes simplex virus type 1 mutant with gamma 34.5 and LAT deletions effectively oncolyses human U87 glioblastomas in nude mice. Neurosurgery 2002;50:599-605.
14. Jiang F, Cho KK, Mikkelse T, Tong L, Lew YS, Hochbaum N, Shargorodsky J, Chop M. Tamoxifen increases photodynamic therapeutic response of U87 and U25ln human glioma cells. J Neurooncol 2002;56:51-88.
15. Chattopadhyay N, Butters RR, Brown EM. Agonists of the retinoic acid-and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Brain Res Mol Brain Res 2001 19;87:100-108.
16. Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, Vevea JM, Cohen MS, Pykett IL, Brady TJ. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 1990;14:538-546.
17. Rosen BR, BEllivear JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
18. van Zijl PC, Eleff SM, Ulatowski JA, Oja JM, Ulug AM, Traystman RJ, Kauppinen RA. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med 1998;4:159-167.
19. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45.
20. Williams D, Detre J, Leigh J, Koretsky A. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992;89:212-216.
21. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999;19:701-735.
22. Detre JA, Alsop DC, Vives LR, Maccotta L, Teener JW, Raps EC. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 1998;50:633-641.
23. Silva A, Kim SG, Garwood M. Imaging blood flow in brain tumors using arterial spin labeling. Magn Reson Med 2000;44:169-173.
24. Brown SL, Ewing R, Kolozsvary A, Butt S, Cao Y, Kim JH. Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration. Int J Radiat Oncol Biol Phys 1999;43:627-633.
25. Herscovitch P, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J Cereb Blood Flow Metab 1985;5:65-69.
26. Nelder JA, Mead R. A simplex method for function minimization. Comput J 1965;7:308-313.
27. Gering D, Nabavi A, Kikinis R, Eric W, Grimson L, Hata N, Everett P, Jolesz F, Wells III W. An integrated visualization system for surgical planning and guidance using image fusion and interventional imaging. Medical image computing and computer-assisted intervention (MIC-CAI). September 19-22, 1999, NeuroMedia Group, University of Kent at Canterbury, Cambridge, UK, 1999.
28. Sun Y, Zhou J, Stayner C, Munasinghe J, Shen X, Beier D, Albert M. Magnetic resonance imaging assessment of a murine model of recessive polycystic kidney disease. Comp Med 2002;52:433-438.
29. Endrich B, Reinhold HS, Gross JF, Intaglietta M. Tissue perfusion inhomogeneity during early tumor growth in rats. J Natl Cancer Inst 1979;62:387-395.
30. Konerding MA, Steinberg F, van Ackern C, Budach V, Streffer C. Vascular patterns of tumors: scanning and transmission electron microscopic studies on human xenografts. Strahlenther Onkol 1992;168:444-452.
31. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160:985-1000.
32. Vajkoczy P, Menger MD. Vascular microenvironment in gliomas. J Neurooncol 2000;50:99-108.
33. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-2658.
34. Boucher Y, Salehi H, Witwer B, Harsh GR 4th, Jain RK. Interstitial fluid pressure in intracranial tumors in patients and in rodents. Br J Cancer 1997;75:829-836.
35. Zhang W, Williams DS, Detre JA, Koretsky AP. Measurement of brain perfusion by volume-localized NMR spectroscopy using inversion of arterial water spins: accounting for transit time and cross-relaxation. Magn Reson Med 1992;25:362-371.
36. Kim S-G, Ackerman JJH. Quantitative determination of tumor blood flow and perfusion via deuterium nuclear magnetic resonance spectroscopy in mice. Cancer Res 1988;48:3449-3453.
37. Ross BD, Mitchell SL, Merkle H, Garwood M. In vivo 31P and 2H NMR studies of rat brain tumor pH and blood flow during acute hyperglycemia: differential effects between subcutaneous and intracerebral locations. Magn Reson Med 1989;12:219-234.
38. Nelson AL, Algon A, Munasinghe J, Graves O, Goumnerova L, Burstein D, Pomeroy SL, Kim JYH. Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. J Neuro-Oncol 2003;62:259-267.